Related Experiment Videos
Surgical management of hepatic malignancy
David A Kooby1, William R Jarnagin
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, USA.
Cancer Investigation
|June 18, 2004
Summary
Hepatic resection has become safer and more common for liver cancer, significantly improving patient outcomes. While resection is the most effective treatment, further advances are needed to reduce recurrence rates and improve long-term survival.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastroenterology
Background:
- Hepatic resection has transformed over 25 years from a high-risk procedure to a safe, common operation.
- Significant improvements in perioperative outcomes (mortality, blood loss, transfusion, hospital stay) have been achieved.
Purpose of the Study:
- To review the evolution and current status of hepatic resection for hepatobiliary malignancy.
- To highlight the factors contributing to improved outcomes and future directions.
Main Methods:
- Review of advancements in hepatic resection over the past 25 years.
- Analysis of perioperative outcomes and patient selection criteria.
- Discussion of adjunctive therapies and future treatment strategies.
Main Results:
- Hepatic resection is now a viable treatment for selected patients with hepatobiliary malignancy.
- Improved imaging and understanding of clinical variables enhance preoperative assessment and patient selection.
- Resection remains the most effective therapy, though long-term recurrence rates necessitate further systemic agent development.
Conclusions:
- Hepatic resection has evolved into a safe and effective treatment for hepatobiliary malignancies.
- Continued advancements in systemic therapies are crucial for improving long-term survival and potentially expanding resection indications.